Intrinsic Value of S&P & Nasdaq Contact Us

Warby Parker Inc. WRBY NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
52/100
2/7 Pass
SharesGrow Intrinsic Value
$412.15
+1681.1%
Analyst Price Target
$29.33
+26.8%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Warby Parker Inc. (WRBY) trades at a trailing P/E of 1,574.2, forward P/E of 48.0. Trailing earnings yield is 0.06%, forward earnings yield 2.08%. PEG 0.01 (Peter Lynch undervalued ≤1.0). Graham Number is $0.95.

Criteria proven by this page:

  • VALUE (27/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 1,574.2); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY 0.06%).
  • Forward P/E 48.0 (down from trailing 1,574.2) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.01 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 0.06% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 2.08% as earnings recover.
  • Analyst consensus target $29.33 (+26.8% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 52/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
52/100
SG Score
View full scorecard →
VALUE
27/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
58/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
HEALTH
75/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
61/100
→ Income
GROWTH
90/100
→ Income
INCOME
30/100
→ Income

Valuation Snapshot — WRBY

Valuation Multiples
P/E (TTM)1,574.2
Forward P/E48.0
PEG Ratio0.01
Forward PEG0.01
P/B Ratio7.03
P/S Ratio2.94
EV/EBITDA51.4
Per Share Data
EPS (TTM)$0.01
Forward EPS (Est.)$0.48
Book Value / Share$2.99
Revenue / Share$7.08
FCF / Share$0.36
Yields & Fair Value
Earnings Yield0.06%
Forward Earnings Yield2.08%
Dividend Yield0.00%
Graham Number$0.95
SharesGrow IV$412.15 (+1681.1%)
Analyst Target$29.33 (+26.8%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2019 0.0 0.00 82.70 16.38 -
2020 -108.5 28.22 19.68 15.42 -
2021 -36.7 -0.21 18.50 9.78 -
2022 -14.0 0.45 5.41 2.59 -
2023 -26.2 0.60 5.48 2.47 -
2024 -142.9 2.09 8.57 3.78 -
2025 1,628.9 -15.10 7.27 3.07 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $-0.52 $370.46M $-57.54M -15.5%
2020 $-0.50 $393.72M $-55.92M -14.2%
2021 $-1.27 $540.8M $-144.27M -26.7%
2022 $-0.96 $598.11M $-110.39M -18.5%
2023 $-0.54 $669.77M $-63.2M -9.4%
2024 $-0.17 $771.32M $-20.39M -2.6%
2025 $0.01 $871.91M $1.64M 0.2%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.48 $0.39 – $0.58 $981.29M $967.62M – $1.01B 7
2027 $0.65 $0.51 – $0.73 $1.14B $1.12B – $1.2B 7
2028 $0.97 $0.51 – $1.44 $1.57B $1.53B – $1.71B 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message